Compare Illumina, Inc. (ILMN) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Nvidia Corp — how do they compare? Illumina, Inc. trades at $192.55 (market cap $27.94B), while Nvidia Corp trades at $207.39 (market cap $4.92T). The key difference: Nvidia Corp is far larger — about 176.1× Illumina, Inc.'s market cap, and Nvidia Corp pays a 0.49% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | NVDA | |
|---|---|---|
Market Cap | $27.94B | $4.92T |
Sector | Health | Technology |
52-Week High | $194.33 | $235.75 |
52-Week Low | $91.00 | $165.17 |
Enterprise Value | $29.33B | $4.86T |
Dividend Yield | — | 0.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVIDIA (NVDA) trades at $206.97, up 2.05% today, with a neutral technical signal and strong fundamentals. Revenue surged to $130.50B in 2025, with a net income margin of 62.97% and robust cash flow. The stock faces resistance near $207, with support at $201. Analysts maintain a bullish consensus, citing AI leadership and earnings beats.
Outlook remains positive due to AI demand and earnings growth, but risks include competition and market volatility. The consensus price target of $325.86 implies significant upside, supported by institutional confidence and consistent financial performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
